Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 8/20 | 0.47 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.46 |
| ▸ | YARS1 | P54577 | 2/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tyrosine SCHEMBL19809042 | 1.00 | SLC7A5 (0.56) | SLC7A5NAALAD2BACE1BACE2OPRD1 | |
| SCHEMBL29531717 | 0.91 | BACE1 (0.56) | NAALAD2BACE1BACE2OPRD1 | |
| SCHEMBL30947373 | 0.89 | OPRD1 (0.53) | NAALAD2BACE1BACE2OPRD1 | |
| SCHEMBL29462561 | 0.88 | SLC7A5 (0.59) | SLC7A5OPRD1YARS1 | |
| SCHEMBL29531284 | 0.88 | SLC7A5 (0.59) | SLC7A5OPRD1YARS1 | |
| Hydrochloric Acid SCHEMBL30698094 | 0.86 | SLC7A5 (0.58) | SLC7A5OPRD1YARS1 | |
| SCHEMBL31276527 | 0.85 | SLC7A5 (0.56) | SLC7A5OPRD1YARS1 | |
| Tyrosine SCHEMBL1495262 | 0.84 | NAALAD2 (0.64) | SLC7A5NAALAD2BACE1BACE2YARS1 | |
| SCHEMBL29832294 | 0.84 | BACE1 (0.66) | BACE1BACE2OPRD1 | |
| SCHEMBL31062518 | 0.84 | OPRD1 (0.61) | SLC7A5BACE1BACE2OPRD1YARS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2930512-B1 | Biomarkers for fatty liver disease and methods using the same | METABOLON INC (US) | 2018-01-31 | — | — | EP | disclosed |